Risk Factors for Hospital-Acquired Candidemia: A Matched Case-Control Study

Archives of Internal Medicine

Volumn 149, Issue 10, 1989, Pages 2349-2353

  Wey, Sergio B ^a   Mori, Motomi ^a   Pfaller, Michael A ^a   Woolson, Robert F ^a   Wenzel, Richard P ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDIASIS; CASE CONTROL STUDY; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANTIBIOTICS; CANDIDIASIS; CASE-CONTROL STUDIES; CATHETERIZATION, SWAN-GANZ; CROSS INFECTION; HUMAN; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 0024450044     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1989.00390100145030     Document Type: Article

References (36)

1. Braude AI, Rock JA. The syndrome of acute disseminated moniliasis in adults. Arch Intern Med. 1959;104:93-100.
2. Hurley R. Acute disseminated (septicemic) moniliasis in adults and children. Postgrad Med J. 1964;40:644-653.
3. McGowan JE Jr. Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections. Rev Infect Dis. 1985;7(suppl 3): 5357-5370.
4. Centers for Disease Control. Nosocomial Infection Surveillance, 1983. Atlanta, Ga: Centers for Disease Control; 1984. Surveillance Summaries 33, No. 2SS.
5. Morrison AJ, Freer CV, Searcy MA, Landry SM, Wenzel RP. Nosocomial bloodstream infections: secular trends in a statewide surveillance program in Virginia. Infect Control. 1986;7:550-553.
6. Louria DB, Stiff DP, Bennet B. Disseminated moniliasis in the adult. Medicine. 1962;41:307-334.
7. Seelig MS. The role of antibiotics in the pathogenesis of Candida infections. Am J Med. 1966;40:887-917.
8. Bodey GP, Fainstein V. Candidemia. New York, NY: Raven Press; 1985:135-154.
9. Odds FC. Candida and Candidosis. Baltimore, Md: University Park Press; 1979:178-188.
10. Keller MA, Sellers BB Jr, Melish ME, Kaplan GW, Miller KE, Mendoza SA. Systemic candidiasis in infants: a case presentation and literature review. AJDC. 1977;131:1260-1263.
11. Hill HR, Mitchell TH, Matsen JM, Quie PG. Recovery from disseminated candidiasis in a premature neonate. Pediatrics. 1974;53:748-752.
12. Young RC, Bennett JE, Geelhoed GW, Levine AS. Fungemia with compromised host resistance. Ann Intern Med. 1974;80:605-612.
13. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Am J Med. 1981;71:363-370.
14. DeGregorio MW, Lee WMF, Ries CA. Candida infections in a patient with acute leukemia. Am J Med. 1982;73:543-548.
15. Maksymiuk AW, Thogprasert S, Hopper R, Luna M, Fainstein V, Bodey GP. Systemic candidiasis in cancer patients. Am J Med. 1984;77:20-27.
16. Dennis DL, Peterson CG, Fletcher WS. Candida septicemia in the severely traumatized patient. J Trauma. 1985;8:177-185.
17. Law EJ, Kim OJ, Stieritz DD, MacMillan BG. Experience with systemic candidiasis in the burned patient. J Trauma. 1972;12:543-552.
18. Bernhardt HE, Orlando JC, Benfield JR, Hirose FM, Foos RY. Disseminated candidiasis in surgical patients. Surg Gynecol Obstet. 1972;134:819-825.
19. Rose H. Venous catheter-associated candidemia. Am J Med Sci. 1978;275:265-269.
20. Thomas MG, Lang SDR. Intravascular cannula-related sepsis: two years experience. NZ Med J. 1985;98:804-806.
21. Deitch EA, Marini JJ, Huseby JS. Suppurative candida phlebitis of a peripheral vein. J Trauma. 1980;20:618-620.
22. Torres-Rojas JR, Stratton CW, Sanders CV, et al. Candidal suppurative peripheral thrombophlebitis. Ann Intern Med. 1982;96:431-435.
23. Walsh TJ, Bustamente CI, Vhahov D, Standiford HC. Candidal suppurative peripheral thrombophlebitis: recognition, prevention, and management. Infect Control. 1986;7:16-22.
24. Ruthe RC, Andersen BR, Cunningham BL, Epstein RB. Efficacy of granulocyte transfusion in the control of systemic candidiasis in the leukemic host. Blood. 1978;52:493-498.
25. Tchekmedyian NS, Newman K, Moody MR, et al. Case report: special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia. Am J Med Sci. 1986;291:419-424.
26. Klein JJ, Watanakunakorn C. Hospital-acquired fungemia: its natural course and clinical significance. Am J Med. 1979;67:51-58.
27. Pockros PJ, Silberman H. Parenteral nutrition complicated by candidiasis. J Infect Dis. 1982;145:592-593.
28. Williams RJ, Chandler JG, Orloff MJ. Candida septicemia. Arch Surg. 1971;103:8-11.
29. Schimpff SC, Young VM, Greene WH, Vermeulen GD, Moody MR, Wiernik PH. Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potential pathogens. Ann Intern Med. 1972;77:707-714.
30. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642-2645.
31. Breslow NE, Day NE. Statistical Methods in Cancer Research. Geneva, Switzerland: World Health Organization International Agency for Research on Cancer; 1980;1:248-279.
32. Kleinbaun DG, Kupper LL, Morgenstern H. Epidemiology Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982:302-307.
33. SAS Institute Inc. SUGI Supplementary Library User’s Guide, Version 5 Edition. Cary, NC: SAS Institute Inc; 1986.
34. Miller PJ, Wenzel RP. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis. 1987;156:471-477.
35. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer. 1984;53:411-419.
36. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol. 1988;26:429-432.